Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in Taiwan.
Fuu-Jen TsaiPei-Yuu YangChao-Jung ChenJu-Pi LiTe-Mao LiJian-Shiun ChiouChi-Fung ChengPo-Heng ChuangTing-Hsu LinChiu-Chu LiaoShao-Mei HuangBo BanWen-Miin LiangChi-Fung ChengPublished in: BMC complementary medicine and therapies (2020)
CHM, as adjunct therapy, might decrease the risk of overall mortality in patients with decompensated liver cirrhosis. CHM co-prescription patterns and network analysis showed that comprehensive herbal medicines have a protective role against liver fibrosis. Further studies are required to enhance the knowledge of safety and efficacy of CHM in patients with decompensated liver cirrhosis.